OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF
M. Stafford, Declan J. McKenna
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1824-1824
Open Access | Times Cited: 14
M. Stafford, Declan J. McKenna
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1824-1824
Open Access | Times Cited: 14
Showing 14 citing articles:
Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation
Milad Ashrafizadeh, Wei Zhang, Yu Tian, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 229-260
Closed Access | Times Cited: 14
Milad Ashrafizadeh, Wei Zhang, Yu Tian, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 229-260
Closed Access | Times Cited: 14
HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, et al.
Pharmacological Research (2023) Vol. 190, pp. 106732-106732
Open Access | Times Cited: 23
Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, et al.
Pharmacological Research (2023) Vol. 190, pp. 106732-106732
Open Access | Times Cited: 23
Global research landscape and emerging trends of non-coding RNAs in prostate cancer: a bibliometric analysis
Yuliang Zhou, Wenliang Yao, Shenghui Chen, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Yuliang Zhou, Wenliang Yao, Shenghui Chen, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Prostate cancer and the cell cycle: Focusing on the role of microRNAs
Ibrahim M. Elazab, Ola A. El-Feky, Eman G. Khedr, et al.
Gene (2024) Vol. 928, pp. 148785-148785
Closed Access | Times Cited: 3
Ibrahim M. Elazab, Ola A. El-Feky, Eman G. Khedr, et al.
Gene (2024) Vol. 928, pp. 148785-148785
Closed Access | Times Cited: 3
The TGFβ Induced MicroRNAome of the Trabecular Meshwork
Chelsey Doyle, Breedge Callaghan, Anton W. Roodnat, et al.
(2024)
Open Access | Times Cited: 2
Chelsey Doyle, Breedge Callaghan, Anton W. Roodnat, et al.
(2024)
Open Access | Times Cited: 2
Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study
Simone Detassis, Francesca Precazzini, Margherita Grasso, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5573-5573
Open Access | Times Cited: 2
Simone Detassis, Francesca Precazzini, Margherita Grasso, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5573-5573
Open Access | Times Cited: 2
The TGFβ Induced MicroRNAome of the Trabecular Meshwork
Chelsey Doyle, Breedge Callaghan, Anton W. Roodnat, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 1060-1060
Open Access | Times Cited: 2
Chelsey Doyle, Breedge Callaghan, Anton W. Roodnat, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 1060-1060
Open Access | Times Cited: 2
Targeting of AKT1 by miR-143-3p Suppresses Epithelial-to-Mesenchymal Transition in Prostate Cancer
Lee Armstrong, Colin E. Willoughby, Declan J. McKenna
Cells (2023) Vol. 12, Iss. 18, pp. 2207-2207
Open Access | Times Cited: 5
Lee Armstrong, Colin E. Willoughby, Declan J. McKenna
Cells (2023) Vol. 12, Iss. 18, pp. 2207-2207
Open Access | Times Cited: 5
Hyperglycemia and microRNAs in prostate cancer
Valentina Russo, Lara Tamburrino, Simone Morselli, et al.
Prostate Cancer and Prostatic Diseases (2024)
Closed Access | Times Cited: 1
Valentina Russo, Lara Tamburrino, Simone Morselli, et al.
Prostate Cancer and Prostatic Diseases (2024)
Closed Access | Times Cited: 1
The Suppression of the Epithelial to Mesenchymal Transition in Prostate Cancer through the Targeting of MYO6 Using MiR-145-5p
Lee Armstrong, Colin E. Willoughby, Declan J. McKenna
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4301-4301
Open Access | Times Cited: 1
Lee Armstrong, Colin E. Willoughby, Declan J. McKenna
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4301-4301
Open Access | Times Cited: 1
Bioinformatics and Experimental Insights Into miR ‐182, hsa_circ_0070269, and circ‐102,166 as Therapeutic Targets for HCV ‐Associated HCC
Yasmeen Ishaq, Bisma Rauff, Badr Alzahrani, et al.
Cancer Reports (2024) Vol. 7, Iss. 12
Closed Access
Yasmeen Ishaq, Bisma Rauff, Badr Alzahrani, et al.
Cancer Reports (2024) Vol. 7, Iss. 12
Closed Access
PCAT19: the role in cancer pathogenesis and beyond
Haijun Hu, Hongliang Luo, Ziqing Deng
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Haijun Hu, Hongliang Luo, Ziqing Deng
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis
Edyta Barnaś, Joanna Skręt‐Magierło, Sylwia Paszek, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 712-712
Open Access | Times Cited: 1
Edyta Barnaś, Joanna Skręt‐Magierło, Sylwia Paszek, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 712-712
Open Access | Times Cited: 1
MicroRNA´S COMO BIOMARCADORES DO CÂNCER DE PRÓSTATA: UMA REVISÃO INTEGRATIVA
João Junior Scapin Telis, Ruan Pimenta, Natália Araújo Teixeira, et al.
Revista Foco (2023) Vol. 16, Iss. 11, pp. e3597-e3597
Open Access
João Junior Scapin Telis, Ruan Pimenta, Natália Araújo Teixeira, et al.
Revista Foco (2023) Vol. 16, Iss. 11, pp. e3597-e3597
Open Access
